Short Sleep Duration Linked to Increased Risk for Developing T2D
By Elana Gotkine HealthDay Reporter
THURSDAY, March 7, 2024 -- Habitual short sleep duration is associated with an increased risk for developing type 2 diabetes (T2D), according to a study published online March 5 in JAMA Network Open.
Diana Aline Nôga, Ph.D., from Uppsala University in Sweden, and colleagues examined the associations of type of diet and duration of sleep with T2D development in a cohort study. A total of 247,867 participants were categorized into four sleep duration groups: normal, and mild-, moderate-, and extreme-short (seven to eight, six, five, and three to four hours per day, respectively).
The researchers found that 3.2 percent of the participants were diagnosed with T2D during follow-up. Individuals with five hours or less of daily sleep had a significant increase in the risk for T2D after adjustment for confounding variables, with adjusted hazard ratios of 1.16 and 1.41 for individuals sleeping five hours and three to four hours per day, respectively, compared with those with normal sleep duration. The risk for T2D was reduced for individuals with the healthiest dietary patterns (hazard ratio, 0.75). Even for individuals following a healthy diet, the association between short sleep duration and an increased risk for T2D persisted; no multiplicative interaction was seen between sleep duration and healthy diet score.
"This cohort study did not yield compelling evidence to support the notion that maintaining a diet characterized by a low consumption of red meat and processed meat products and a high intake of fruits, vegetables, and fish can sufficiently mitigate the risk of developing T2D associated with habitual short sleep duration," the authors write.
One author disclosed receipt of a grant from the Novo Nordisk Foundation.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted March 2024
Read this next
Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM
FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...
Short Sleep Duration Throughout Childhood Tied to Psychosis Risk in Young Adulthood
WEDNESDAY, May 29, 2024 -- Persistent shorter sleep duration across childhood may be a risk factor for subsequent psychosis in young adulthood, according to a study published...
Demographic, Clinical, Financial Factors Tied to GLP-1 Agonist Discontinuation
WEDNESDAY, May 29, 2024 -- Specific demographic, clinical, and financial characteristics are associated with glucagon-like peptide 1 (GLP-1) receptor agonist discontinuation...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.